Khosseĭn A, Mareev V Iu, Ageev F T, Sazonova L N, Lobova N M
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1988;11(1):78-81.
15 patients with primary pulmonary hypertension (PPH) were studied. An acute test with 20 mg nifedipine (N) sublingually was performed and the pulmonary artery pressure (PAP) was measured. N had manifest arterolodilating effect in the systemic and especially pulmonary circulation, induced decrease in the total peripheral and total pulmonary vascular resistance (TPerVR and TPulVR) by 21.7 and 25.3%, correspondingly. N had principal effect on pulmonary arterioles (TPerVR/TPulVR ratio increased by 16.9%). Systolic and diastolic PAP decreased in this case by 15.2 and 18.4%, correspondingly. All the patients demonstrated increase in cardiac output (on the average by 17.0%) and insignificant increase in heart rate (7.4%).
对15例原发性肺动脉高压(PPH)患者进行了研究。进行了一项舌下含服20毫克硝苯地平(N)的急性试验,并测量了肺动脉压(PAP)。N在体循环尤其是肺循环中具有明显的小动脉扩张作用,使总外周血管阻力和总肺血管阻力(TPerVR和TPulVR)分别降低了21.7%和25.3%。N对肺小动脉有主要作用(TPerVR/TPulVR比值增加了16.9%)。在这种情况下,收缩压和舒张压PAP分别降低了15.2%和18.4%。所有患者的心输出量均增加(平均增加17.0%),心率略有增加(7.4%)。